The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Jackson, L. A., Anderson, E. J., Rouphael, N. G., Roberts, P. C., Makhene, M., Coler, R. N., McCullough, M. P., Chappell, J. D., Denison, M. R., Stevens, L. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022483 · Cited by 3,237
An inflammatory cytokine signature predicts COVID-19 severity and survival
Del Valle, D. M., Kim-Schulze, S., Huang, H.-H., Beckmann, N. D., Nirenberg, S., Wang, B., Lavin, Y., Swartz, T. H., Madduri, D., Stock, A., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1051-9 · Cited by 2,605
Folegatti, P. M., Ewer, K. J., Aley, P. K., Angus, B., Becker, S., Belij-Rammerstorfer, S., Bellamy, D., Bibi, S., Bittaye, M., Clutterbuck, E. A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31604-4 · Cited by 2,419
Self-citationRobust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Sekine, T., Perez-Potti, A., Rivera-Ballesteros, O., Strålin, K., Gorin, J.-B., Olsson, A., Llewellyn-Lacey, S., Kamal, H., Bogdanovic, G., Muschiol, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.017 · Cited by 1,788
Immunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623
Self-citationMulligan, M. J., Lyke, K. E., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Neuzil, K., Raabe, V., Bailey, R., Swanson, K. A., et al. (2020) · doi:10.1101/2020.06.30.20142570 · Cited by 1,569
Zhu, F.-C., Li, Y.-H., Guan, X.-H., Hou, L.-H., Wang, W.-J., Li, J.-X., Wu, S.-P., Wang, B.-S., Wang, Z., Wang, L., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31208-3 · Cited by 1,382
Self-citationInterim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
Sadoff, J., Le Gars, M., Shukarev, G., Heerwegh, D., Truyers, C., de Groot, A. M., Stoop, J., Tete, S., Van Damme, W., Leroux-Roels, I., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2034201 · Cited by 1,208
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
Wajnberg, A., Amanat, F., Firpo, A., Altman, D. R., Bailey, M. J., Mansour, M., McMahon, M., Meade, P., Mendu, D. R., Muellers, K., et al. (2020) · Science · doi:10.1126/science.abd7728 · Cited by 1,195
Research works printed but not linked: 3
- Sahin, U. et al. Concurrent human antibody and TH1 type T-cell responses elicited by a COVID-19 RNA vaccine. Preprint at https://www.medrxiv.org/content/10.1101/2020.07.17.20140533v1 (2020). · doi:10.1101/2020.07.17.20140533v1
- Wajnberg, A. et al. SARS-CoV-2 infection induces robust, neutralizing antibody responses that are stable for at least three months. Preprint at https://www.medrxiv.org/content/10.1101/2020.07.14.20151126v1 (2020). · doi:10.1101/2020.07.14.20151126
- Mulligan, M. J. et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature 586, 589–593 (2020). · doi:10.1038/s41586-020-2639-4 · Paper page
Cited by
Voysey, M., Costa Clemens, S. A., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., Angus, B., Baillie, V. L., Barnabas, S. L., Bhorat, Q. E., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00432-3 · Cited by 1,119
Self-citationCorrelates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
Feng, S., Phillips, D. J., White, T., Sayal, H., Aley, P. K., Bibi, S., Dold, C., Fuskova, M., Gilbert, S. C., Hirsch, I., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01540-1 · Cited by 1,163
Self-citationAge-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2
Collier, D. A., Ferreira, I. A. T. M., Kotagiri, P., Datir, R. P., Lim, E. Y., Touizer, E., Meng, B., Abdullahi, A., The CITIID-NIHR BioResource COVID-19 Collaboration, Principal Investigators, et al. (2021) · Nature · doi:10.1038/s41586-021-03739-1 · Cited by 751
Self-citationEmary, K. R. W., Golubchik, T., Aley, P. K., Ariani, C. V., Angus, B., Bibi, S., Blane, B., Bonsall, D., Cicconi, P., Charlton, S., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00628-0 · Cited by 603
Self-citationImmunological mechanisms of vaccine-induced protection against COVID-19 in humans
Sadarangani, M., Marchant, A., & Kollmann, T. R. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00578-z · Cited by 560
Metadata
- Authors
- Ewer, K. J., Barrett, J. R., Belij-Rammerstorfer, S., Sharpe, H., Makinson, R., Morter, R., Flaxman, A., Wright, D., Bellamy, D., Bittaye, M., Dold, C., Provine, N. M., Aboagye, J., Fowler, J., Silk, S. E., Alderson, J., Aley, P. K., Angus, B., Berrie, E., Bibi, S., Cicconi, P., Clutterbuck, E. A., Chelysheva, I., Folegatti, P. M., Fuskova, M., Green, C. M., Jenkin, D., Kerridge, S., Lawrie, A., Minassian, A. M., Moore, M., Mujadidi, Y., Plested, E., Poulton, I., Ramasamy, M. N., Robinson, H., Song, R., Snape, M. D., Tarrant, R., Voysey, M., Watson, M. E. E., Douglas, A. D., Hill, A. V. S., Gilbert, S. C., Pollard, A. J., Lambe, T., the Oxford COVID Vaccine Trial Group, Ali, A., Allen, E., Baker, M., Barnes, E., Borthwick, N., Boyd, A., Brown-O’Sullivan, C., Burgoyne, J., Byard, N., Puig, I. C., Cappuccini, F., Cho, J.-S., Cicconi, P., Clark, E., Crocker, W. E. M., Datoo, M. S., Davies, H., Donnellan, F. R., Dunachie, S. J., Edwards, N. J., Elias, S. C., Furze, J., Gilbride, C., Gorini, G., Gupta, G., Harris, S. A., Hodgson, S. H. C., Hou, M. M., Jackson, S., Jones, K., Kailath, R., King, L., Larkworthy, C. W., Li, Y., Lias, A. M., Linder, A., Lipworth, S., Ramon, R. L., Madhavan, M., Marlow, E., Marshall, J. L., Mentzer, A. J., Morrison, H., Moya, N., Mukhopadhyay, E., Noé, A., Nugent, F. L., Pipini, D., Pulido-Gomez, D., Lopez, F. R., Ritchie, A. J., Rudiansyah, I., Salvador, S., Sanders, H., Satti, I., Shea, A., Silk, S., Spencer, A. J., Tanner, R., Taylor, I. J., Themistocleous, Y., Thomas, M., Tran, N., Truby, A., Turner, C., Turner, N., Ulaszewska, M., Worth, A. T., Kingham-Page, L., Alvarez, M. P. P., Anslow, R., Bates, L., Beadon, K., Beckley, R., Beveridge, A., Bijker, E. M., Blackwell, L., Burbage, J., Camara, S., Carr, M., Colin-Jones, R., Cooper, R., Cunningham, C. J., Demissie, T., Maso, C. D., Douglas, N., Drake-Brockman, R., Drury, R. E., Emary, K. R. W., Felle, S., Feng, S., Silva, C. F. D., Ford, K. J., Francis, E., Gracie, L., Hamlyn, J., Hanumunthadu, B., Harrison, D., Hart, T. C., Hawkins, S., Hill, J., Howe, E., Howell, N., Jones, E., Keen, J., Kelly, S., Kerr, D., Khan, L., Kinch, J., Koleva, S., Lees, E. A., Lelliott, A., Liu, X., Marchevsky, N. G., Marinou, S., McEwan, J., Morey, E., Morshead, G., Muller, J., Munro, C., Murphy, S., Mweu, P., Nuthall, E., O’Brien, K., O’Connor, D., O’Reilly, P. J., Oguti, B., Osborne, P., Owino, N., Parker, K., Pfafferott, K., Phillips, D., Provstgaard-Morys, S., Ratcliffe, H., Rawlinson, T., Rhead, S., Roberts, H., Sanders, K., Silva-Reyes, L., Rollier, C. S., Smith, C. C., Smith, D. J., Stockdale, L., Szigeti, A., Thomas, T. M., Thompson, A., Tomic, A., Tonks, S., Varughese, R., Verheul, M. K., Vichos, I., Walker, L., White, C., White, R., Yao, X. L., Conlon, C. P., Frater, J., Cifuentes, L., Baleanu, I., Bolam, E., Boland, E., Brenner, T., Damratoski, B. E., Datta, C., Muhanna, O. E., Fisher, R., Galian-Rubio, P., Hodges, G., Jackson, F., Liu, S., Loew, L., Morgans, R., Morris, S. J., Olchawski, V., Oliveria, C., Parracho, H., Pabon, E. R., Tahiri-Alaoui, A., Taylor, K., Williams, P., Zizi, D., Arbe-Barnes, E. H., Baker, P., Batten, A., Downing, C., Drake, J., English, M. R., Henry, J. A., Iveson, P., Killen, A., King, T. B., Larwood, J. P. J., Mallett, G., Mansatta, K., Mirtorabi, N., Patrick-Smith, M., Perring, J., Radia, K., Roche, S., Schofield, E., Naude, R. T. W., Towner, J., Baker, N., Bewley, K. R., Brunt, E., Buttigieg, K. R., Carroll, M. W., Charlton, S., Coombes, N. S., Elmore, M. J., Godwin, K., Hallis, B., Knott, D., McInroy, L., Shaik, I., Thomas, K., Tree, J. A., Blundell, C. L., Cao, M., Kelly, D., Schmid, A., Skelly, D. T., Themistocleous, A., Dong, T., Field, S., Hamilton, E., Kelly, E., Klenerman, P., Knight, J. C., Lie, Y., Petropoulos, C., Sedik, C., Wrin, T., Meddaugh, G., Peng, Y., Screaton, G., & Stafford, E.
- Venue
- Nature Medicine
- Published
- 2020-12-17
- Volume
- 27
- Issue
- 2
- Pages
- 270-278
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W3108666979
- Cited by
- 586
- References
- 39
- FWCI
- 14.15
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-05-21)
- Open access
- bronze
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Funders
- DH | National Institute for Health Research (MC_PC_19055)
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases (HHSN272201400008C)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial. https://app.cochat.ai/papers/10.1038/s41591-020-01194-5
- The paper
- Ewer, K. J., Barrett, J. R., Belij-Rammerstorfer, S., Sharpe, H., Makinson, R., Morter, R., Flaxman, A., Wright, D., Bellamy, D., Bittaye, M., Dold, C., Provine, N. M., Aboagye, J., Fowler, J., Silk, S. E., Alderson, J., Aley, P. K., Angus, B., Berrie, E., . . . Stafford, E. (2021). T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial. Nature Medicine. https://doi.org/10.1038/s41591-020-01194-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.